Evidence that Argos is an antagonistic ligand of the EGF receptor.
about
Argos inhibits epidermal growth factor receptor signalling by ligand sequestrationThe divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligandsHerstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.A fly's eye view of EGF receptor signallingThe leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.Cross signaling, cell specificity, and physiology.Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing FieldNegative regulation of ErbB family receptor tyrosine kinasesA functional domain of Dof that is required for fibroblast growth factor signaling.Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk.Drosophila Condensin II subunit Chromosome-associated protein D3 regulates cell fate determination through non-cell-autonomous signaling.Mechanisms of ErbB receptor negative regulation and relevance in cancer.Receptor tyrosine phosphatases control tracheal tube geometries through negative regulation of Egfr signaling.Receptor binding specificities of Herstatin and its intron 8-encoded domain.Regulatory mechanisms of EGFR signalling during Drosophila eye development.Conserved cross-interactions in Drosophila and Xenopus between Ras/MAPK signaling and the dual-specificity phosphatase MKP3.
P2860
Q28278895-54862017-ADE3-465C-8A38-31BDBC7FFA94Q28584296-4E89C6B8-2D32-4884-9778-F5C117C36D03Q34122281-BF9B4599-11FD-4820-865A-6EB3BD1E92D2Q34165208-B35E47C9-A141-43B0-BD78-F07E0CDCF3E9Q34345557-0B165CF4-4501-477D-8D07-099D3750C8DBQ34675896-B8FE7174-0DAF-4E64-87C0-4489C2DBC650Q34996130-0EEC1746-B0EC-4BB2-96C6-5F8FAD4E2FB8Q35634554-8790F383-8DB8-4C1A-83B8-230E68FA3098Q36572473-A4F4E85F-D0EA-4CA2-A7DE-5B4EE9E64634Q36648414-F33CBE76-804E-43FB-AD12-C30D5E3DB2CCQ37217377-9DA9149F-0505-4E0A-9DF9-1E9AA58AD9C9Q37244805-F3B16EF7-A24B-479E-87F7-866BBA0DB7D0Q37314327-DE0BF5D6-E17A-49B9-A218-B3C2D779792DQ38340100-79FB685A-D19D-4B6C-AC30-09AA2F98C1FDQ38758386-18E0E4BE-B74D-4D2A-9D17-927CDF46F04CQ45259895-8E290CCE-13E2-488A-9141-7F3C97C54400
P2860
Evidence that Argos is an antagonistic ligand of the EGF receptor.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Evidence that Argos is an antagonistic ligand of the EGF receptor.
@en
Evidence that Argos is an antagonistic ligand of the EGF receptor.
@nl
type
label
Evidence that Argos is an antagonistic ligand of the EGF receptor.
@en
Evidence that Argos is an antagonistic ligand of the EGF receptor.
@nl
prefLabel
Evidence that Argos is an antagonistic ligand of the EGF receptor.
@en
Evidence that Argos is an antagonistic ligand of the EGF receptor.
@nl
P2860
P356
P1433
P1476
Evidence that Argos is an antagonistic ligand of the EGF receptor.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203702
P407
P577
2000-07-01T00:00:00Z